---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-042948"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:39:32.850749+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Aquestive amends bylaws: shortens nomination look-back to 2 years, updates terminology

## Summary
- Stockholder nomination look-back period shortened from three years to two years.
- All references to 'chairman' replaced with 'chair' for modernization.
- Amendments approved by Board and effective immediately on October 16, 2024.

## SEC filing metadata
- accession: 0001628280-24-042948
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/0001628280-24-042948-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024042948/aqst-20241016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-042948
- JSON: https://secwatch.observer/filing/0001628280-24-042948.json
- Plain text: https://secwatch.observer/filing/0001628280-24-042948.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.